NPI: 1912919481 · NORFOLK, VA 23507 · Clinical Social Worker · NPI assigned 08/13/2006
Authorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
| Authorized Official | ABSHIRE, KATHRYN (SENIOR VP/CFO) |
| NPI Enumeration Date | 08/13/2006 |
Other providers sharing the same authorized official: ABSHIRE, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 452,571 | $27.97M |
| 2019 | 462,321 | $25.81M |
| 2020 | 377,461 | $29.63M |
| 2021 | 567,444 | $41.43M |
| 2022 | 628,011 | $51.47M |
| 2023 | 676,411 | $57.64M |
| 2024 | 584,974 | $54.22M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 186,498 | 59,845 | $23.75M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 115,764 | 106,716 | $22.25M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 138,790 | 129,975 | $19.25M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 136,700 | 126,608 | $12.43M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 35,496 | 32,959 | $10.78M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 52,600 | 49,935 | $10.52M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 128,004 | 36,927 | $9.60M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 25,947 | 24,040 | $9.29M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 109,758 | 36,882 | $7.42M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 39,787 | 36,904 | $7.04M |
| 41899 | Unlisted procedure, dentoalveolar structures | 4,087 | 3,852 | $7.01M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 29,828 | 27,762 | $6.42M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,225 | 1,997 | $4.77M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 4,619 | 4,490 | $4.38M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2,191 | 2,054 | $4.33M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6,609 | 6,433 | $4.27M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,792 | 4,534 | $4.10M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 3,039 | 2,784 | $3.96M |
| 93304 | 8,604 | 8,089 | $3.93M | |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,449 | 8,609 | $3.81M |
| 67311 | 1,399 | 1,286 | $3.78M | |
| G0378 | Hospital observation service, per hour | 12,412 | 6,579 | $3.58M |
| 95782 | 2,690 | 2,625 | $2.86M | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 37,565 | 21,456 | $2.64M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 4,547 | 4,346 | $2.53M |
| 42830 | 1,354 | 1,297 | $2.52M | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 23,739 | 22,354 | $2.44M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,362 | 1,044 | $2.26M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 36,277 | 34,063 | $2.02M |
| 76770 | 10,066 | 9,620 | $1.96M | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2,478 | 2,098 | $1.75M |
| 92523 | 10,854 | 10,542 | $1.71M | |
| 70450 | Computed tomography, head or brain; without contrast material | 4,500 | 4,252 | $1.69M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,192 | 2,060 | $1.57M |
| 99215 | Prolong outpt/office vis | 11,610 | 11,057 | $1.56M |
| 87631 | 43,812 | 40,745 | $1.55M | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3,050 | 2,704 | $1.54M |
| 93325 | 14,774 | 13,590 | $1.51M | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,854 | 4,214 | $1.46M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,061 | 7,609 | $1.40M |
| 54161 | 728 | 708 | $1.32M | |
| 94010 | 19,291 | 18,675 | $1.30M | |
| 71046 | Radiologic examination, chest; 2 views | 34,915 | 32,496 | $1.22M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10,064 | 7,721 | $1.20M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,987 | 1,889 | $1.20M |
| 97161 | 6,545 | 6,344 | $1.16M | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,729 | 5,397 | $1.16M |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7,086 | 6,594 | $1.15M |
| P9016 | Red blood cells, leukocytes reduced, each unit | 2,097 | 1,839 | $1.13M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,547 | 1,443 | $1.12M |
| 99217 | 1,902 | 1,693 | $1.10M | |
| 93308 | 2,914 | 2,781 | $1.09M | |
| 95819 | 2,747 | 2,687 | $1.07M | |
| 99218 | 2,482 | 2,218 | $1.02M | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 9,992 | 9,471 | $979K |
| 36430 | 2,517 | 2,061 | $918K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7,177 | 6,913 | $906K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,919 | 1,862 | $829K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 23,916 | 22,198 | $816K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 25,199 | 8,926 | $787K |
| 97162 | 4,409 | 4,283 | $772K | |
| 87486 | 44,027 | 40,908 | $765K | |
| J3490 | Unclassified drugs | 105,041 | 51,303 | $731K |
| 80053 | Comprehensive metabolic panel | 51,129 | 44,313 | $715K |
| J3535 | Drug administered through a metered dose inhaler | 25,022 | 22,525 | $703K |
| 74018 | 14,565 | 13,203 | $701K | |
| 97165 | 4,176 | 4,073 | $696K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,791 | 2,719 | $679K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5,645 | 5,504 | $660K |
| 90791 | Psychiatric diagnostic evaluation | 3,708 | 3,474 | $627K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,680 | 1,964 | $603K |
| 12011 | 2,329 | 2,240 | $597K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,448 | 2,288 | $555K |
| 93321 | 11,468 | 10,738 | $555K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 25,130 | 24,326 | $552K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 47,086 | 41,272 | $533K |
| 93976 | 4,317 | 4,073 | $511K | |
| 95812 | 972 | 942 | $504K | |
| 87581 | 44,023 | 40,906 | $491K | |
| 74019 | 12,088 | 11,289 | $484K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,755 | 9,187 | $474K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 82,423 | 70,424 | $455K |
| 72082 | 5,396 | 5,232 | $451K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,113 | 6,690 | $448K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,778 | 1,574 | $446K |
| 96161 | 12,980 | 12,141 | $433K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3,265 | 3,194 | $431K |
| 70360 | 6,460 | 6,267 | $421K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 883 | 859 | $407K |
| 94060 | 4,286 | 4,097 | $406K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 43,381 | 41,342 | $402K |
| 90834 | Psychotherapy, 45 minutes with patient | 4,407 | 2,713 | $392K |
| 12001 | 1,443 | 1,382 | $381K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,362 | 2,255 | $380K |
| 95816 | 1,528 | 1,426 | $369K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,863 | 8,647 | $365K |
| 96415 | 905 | 580 | $364K | |
| 73564 | 5,421 | 4,702 | $334K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 32,028 | 30,269 | $330K |
| 73610 | 7,319 | 6,775 | $328K | |
| 76870 | 2,205 | 2,062 | $320K | |
| 92551 | 1,818 | 1,696 | $314K | |
| 92522 | 1,958 | 1,926 | $313K | |
| 97803 | 3,365 | 3,237 | $294K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,258 | 7,095 | $294K |
| 92526 | 3,836 | 1,770 | $293K | |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 1,098 | 1,040 | $290K |
| 76536 | 1,737 | 1,673 | $289K | |
| 70486 | 1,139 | 1,105 | $275K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 17,208 | 16,518 | $267K |
| G0390 | Trauma response team associated with hospital critical care service | 362 | 347 | $266K |
| 76885 | 1,502 | 1,333 | $262K | |
| 73630 | 6,741 | 6,003 | $261K | |
| 73100 | 3,969 | 3,506 | $260K | |
| 76937 | 2,844 | 2,448 | $260K | |
| 77072 | 4,088 | 3,992 | $258K | |
| 29125 | 2,275 | 2,105 | $258K | |
| 73090 | 5,259 | 4,485 | $256K | |
| 73590 | 5,400 | 4,567 | $254K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 17,670 | 16,712 | $252K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 20,655 | 14,912 | $249K |
| 25600 | 387 | 383 | $234K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 10,383 | 9,991 | $230K |
| 76882 | 1,634 | 1,566 | $229K | |
| 74240 | 1,225 | 1,183 | $227K | |
| 73140 | 5,606 | 5,111 | $226K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 17,198 | 16,505 | $225K |
| 73521 | 3,699 | 3,546 | $221K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 35,082 | 32,247 | $219K |
| 96127 | 4,978 | 4,760 | $210K | |
| 72081 | 3,639 | 3,552 | $208K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 214,129 | 123,587 | $206K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7,495 | 6,374 | $205K |
| 43762 | 944 | 848 | $204K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 386 | 366 | $204K |
| 97802 | 3,739 | 3,654 | $203K | |
| 87507 | 2,291 | 2,146 | $202K | |
| 99174 | 1,891 | 1,833 | $192K | |
| 93320 | 3,035 | 2,682 | $187K | |
| 29515 | 1,589 | 1,425 | $186K | |
| 83655 | 12,357 | 11,913 | $185K | |
| 84439 | 18,427 | 17,717 | $184K | |
| 40819 | 110 | 96 | $176K | |
| 73070 | 2,567 | 2,209 | $171K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 14,839 | 12,322 | $171K |
| 10060 | 532 | 506 | $168K | |
| 36415 | Collection of venous blood by venipuncture | 52,793 | 49,443 | $164K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 22,107 | 20,965 | $164K |
| 80050 | General health panel | 11,818 | 11,426 | $163K |
| 96450 | 309 | 228 | $162K | |
| 73130 | 3,604 | 3,310 | $156K | |
| 93225 | 1,359 | 1,230 | $155K | |
| 86922 | 3,247 | 2,763 | $153K | |
| 95700 | 853 | 810 | $152K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1,999 | 1,902 | $152K |
| 49591 | 29 | 29 | $152K | |
| 96409 | 1,220 | 713 | $147K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,323 | 1,858 | $146K |
| 73110 | 3,243 | 3,031 | $144K | |
| 96367 | 1,350 | 925 | $144K | |
| 29105 | 1,225 | 1,147 | $142K | |
| 97535 | Self-care/home management training, each 15 minutes | 3,278 | 2,031 | $142K |
| 86140 | 21,191 | 19,527 | $141K | |
| 80061 | Lipid panel | 18,090 | 17,431 | $140K |
| 99173 | 4,749 | 4,632 | $140K | |
| 72100 | 1,944 | 1,898 | $140K | |
| 74230 | 1,026 | 966 | $140K | |
| 87506 | 1,379 | 1,325 | $139K | |
| 73560 | 2,311 | 1,871 | $138K | |
| 73080 | 2,976 | 2,687 | $132K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 27,457 | 25,634 | $132K |
| 83036 | Hemoglobin; glycosylated (A1C) | 19,164 | 18,435 | $132K |
| 95951 | 212 | 133 | $131K | |
| 51600 | 509 | 473 | $127K | |
| 73552 | 2,311 | 1,988 | $127K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 34,642 | 30,870 | $127K |
| 81025 | 18,005 | 16,425 | $126K | |
| J2704 | Injection, propofol, 10 mg | 29,579 | 25,542 | $124K |
| 53020 | 103 | 99 | $122K | |
| 99224 | 92 | 61 | $120K | |
| 90837 | Psychotherapy, 53 minutes with patient | 1,117 | 735 | $120K |
| 87040 | 5,758 | 5,157 | $120K | |
| 73030 | 2,108 | 1,894 | $118K | |
| 94664 | 13,877 | 13,028 | $116K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 799 | 759 | $114K |
| 73620 | 1,933 | 1,536 | $109K | |
| 86902 | 1,872 | 1,635 | $107K | |
| 73600 | 1,690 | 1,475 | $106K | |
| 93226 | 906 | 837 | $105K | |
| 97167 | 1,027 | 953 | $101K | |
| 74455 | 469 | 435 | $100K | |
| 73562 | 2,265 | 1,976 | $99K | |
| 84443 | Thyroid stimulating hormone (TSH) | 11,031 | 10,618 | $98K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 36,414 | 32,575 | $95K |
| 99381 | 849 | 759 | $94K | |
| 81001 | 25,458 | 23,335 | $92K | |
| 96130 | 125 | 107 | $90K | |
| 99051 | 38,300 | 36,161 | $89K | |
| 82728 | 11,119 | 10,381 | $89K | |
| 87077 | 14,180 | 12,720 | $85K | |
| 70250 | 1,431 | 1,339 | $85K | |
| 76506 | 529 | 475 | $85K | |
| 36592 | 3,991 | 3,448 | $81K | |
| 96160 | 2,390 | 2,350 | $80K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 12,243 | 11,671 | $79K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,294 | 1,232 | $79K |
| 90686 | 8,930 | 8,404 | $79K | |
| 83020 | 4,850 | 4,486 | $78K | |
| J2357 | Injection, omalizumab, 5 mg | 1,163 | 684 | $75K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 390 | 348 | $74K |
| 82784 | 9,812 | 9,270 | $72K | |
| 70491 | 172 | 167 | $72K | |
| 83516 | 7,574 | 7,400 | $71K | |
| 73000 | 1,335 | 1,251 | $70K | |
| 96376 | 2,133 | 1,449 | $69K | |
| 77077 | 1,041 | 1,010 | $67K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 643 | 615 | $66K |
| 90832 | Psychotherapy, 30 minutes with patient | 935 | 648 | $66K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 113 | 102 | $66K |
| 97163 | 1,184 | 1,117 | $66K | |
| 73660 | 1,674 | 1,553 | $65K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,406 | 15,830 | $64K |
| 82247 | 9,229 | 6,247 | $64K | |
| 87070 | 7,426 | 6,804 | $62K | |
| 83690 | 7,816 | 7,251 | $62K | |
| 90651 | 2,591 | 2,548 | $62K | |
| 80306 | 5,404 | 5,106 | $61K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,072 | 3,613 | $61K |
| 93788 | 581 | 568 | $60K | |
| 71045 | Radiologic examination, chest; single view | 2,179 | 1,970 | $58K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 4,062 | 3,683 | $58K |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 115 | 91 | $56K |
| 81003 | 26,504 | 24,562 | $56K | |
| 72040 | 1,133 | 1,077 | $55K | |
| 87186 | 8,969 | 8,254 | $55K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 15,401 | 14,142 | $54K |
| 82570 | 10,408 | 9,811 | $53K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 12,983 | 10,266 | $53K |
| 72125 | Computed tomography, cervical spine; without contrast material | 256 | 248 | $52K |
| 85652 | 17,922 | 16,701 | $52K | |
| 97010 | 2,931 | 1,404 | $51K | |
| 72141 | 132 | 127 | $51K | |
| C1889 | Implantable/insertable device, not otherwise classified | 489 | 471 | $51K |
| J0690 | Injection, cefazolin sodium, 500 mg | 8,978 | 6,937 | $51K |
| 90670 | 4,471 | 4,201 | $51K | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 11,890 | 10,025 | $50K |
| 97116 | 1,425 | 749 | $50K | |
| 92610 | 170 | 165 | $50K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,696 | 1,595 | $50K |
| 99195 | 815 | 740 | $49K | |
| 93886 | 221 | 210 | $49K | |
| 82248 | 14,109 | 10,665 | $48K | |
| 90633 | 3,250 | 3,133 | $48K | |
| 92611 | 859 | 807 | $47K | |
| 80047 | 2,650 | 2,479 | $47K | |
| 85045 | 14,045 | 11,479 | $46K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,802 | 1,651 | $46K |
| 49452 | 118 | 100 | $46K | |
| 97016 | 1,411 | 545 | $45K | |
| 97014 | 1,414 | 487 | $45K | |
| 76642 | 285 | 273 | $44K | |
| 80076 | 4,085 | 3,797 | $44K | |
| J1815 | Injection, insulin, per 5 units | 491 | 251 | $44K |
| 97760 | 523 | 496 | $43K | |
| 72070 | 685 | 668 | $42K | |
| 82803 | 3,442 | 3,126 | $42K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 3,387 | 2,852 | $41K |
| 86003 | 2,870 | 2,714 | $40K | |
| 82948 | 4,428 | 3,137 | $40K | |
| A0425 | Ground mileage, per statute mile | 1,779 | 1,564 | $40K |
| 97542 | 480 | 457 | $39K | |
| 64643 | 43 | 39 | $39K | |
| 93786 | 382 | 380 | $39K | |
| 73060 | 912 | 834 | $38K | |
| 82977 | 9,672 | 8,797 | $37K | |
| 72170 | 1,015 | 975 | $37K | |
| 90698 | 4,525 | 4,276 | $36K | |
| 99201 | 336 | 305 | $36K | |
| S9083 | Global fee urgent care centers | 465 | 461 | $36K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 64 | 37 | $36K |
| J8540 | Dexamethasone, oral, 0.25 mg | 10,065 | 9,471 | $35K |
| 73502 | 522 | 485 | $35K | |
| 90680 | 4,130 | 3,842 | $35K | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 9,301 | 8,259 | $34K |
| 54640 | 37 | 37 | $34K | |
| 87510 | 2,583 | 2,492 | $34K | |
| 83735 | 10,538 | 7,627 | $34K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4,710 | 4,483 | $34K |
| 88312 | 4,731 | 4,486 | $33K | |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 13 | 12 | $32K |
| 83001 | 2,046 | 1,973 | $32K | |
| J8597 | Antiemetic drug, oral, not otherwise specified | 884 | 803 | $31K |
| 82330 | 3,986 | 3,430 | $31K | |
| 88300 | 3,250 | 3,046 | $30K | |
| 77073 | 411 | 394 | $29K | |
| 69209 | 405 | 394 | $29K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,176 | 4,257 | $29K |
| 85027 | 6,392 | 5,533 | $29K | |
| 88304 | 2,073 | 1,954 | $28K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 58 | 58 | $28K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 2,320 | 2,047 | $27K |
| C1769 | Guide wire | 913 | 780 | $27K |
| 97763 | 529 | 503 | $26K | |
| 84146 | 1,840 | 1,768 | $25K | |
| 86901 | 4,967 | 4,179 | $24K | |
| 69210 | 163 | 148 | $24K | |
| 87660 | 2,581 | 2,490 | $24K | |
| 29075 | 92 | 92 | $23K | |
| 86592 | 4,061 | 3,880 | $23K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 9,880 | 8,640 | $23K |
| 83880 | 1,021 | 906 | $22K | |
| J1644 | Injection, heparin sodium, per 1000 units | 7,290 | 901 | $22K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,729 | 6,733 | $22K |
| 84100 | 13,961 | 8,505 | $22K | |
| 86850 | 4,463 | 3,868 | $21K | |
| 83550 | 5,542 | 5,034 | $21K | |
| 85007 | 5,276 | 4,500 | $21K | |
| 86038 | 2,785 | 2,665 | $21K | |
| 86900 | 4,968 | 4,179 | $21K | |
| 92609 | 499 | 218 | $20K | |
| 96112 | 20 | 20 | $20K | |
| 29405 | 92 | 26 | $20K | |
| 82785 | 2,150 | 2,052 | $20K | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 1,684 | 1,187 | $20K |
| 90671 | 865 | 824 | $20K | |
| 83540 | 6,167 | 5,589 | $19K | |
| 80197 | 2,300 | 1,431 | $19K | |
| 76942 | 233 | 189 | $19K | |
| 80143 | 672 | 645 | $19K | |
| 85018 | 5,745 | 3,833 | $19K | |
| J7342 | Instillation, ciprofloxacin otic suspension, 6 mg | 914 | 863 | $19K |
| 82150 | 2,658 | 2,503 | $18K | |
| 90677 | 1,290 | 1,208 | $18K | |
| 90715 | 1,790 | 1,745 | $18K | |
| 36591 | 630 | 489 | $18K | |
| 72197 | 28 | 25 | $18K | |
| 87480 | 2,565 | 2,475 | $18K | |
| 82947 | 3,843 | 3,497 | $18K | |
| 95805 | 27 | 27 | $17K | |
| 90744 | 2,295 | 2,113 | $17K | |
| 85610 | 5,505 | 4,641 | $17K | |
| 90696 | 1,294 | 1,273 | $17K | |
| 82043 | 6,140 | 5,905 | $16K | |
| 80179 | 642 | 621 | $16K | |
| 97755 | 72 | 65 | $16K | |
| A4580 | Cast supplies (e.g., plaster) | 623 | 601 | $15K |
| 85660 | 2,201 | 1,958 | $15K | |
| 90619 | 1,050 | 1,042 | $15K | |
| 87205 | 4,214 | 3,808 | $15K | |
| 90697 | 2,052 | 1,915 | $15K | |
| 95811 | 12 | 12 | $15K | |
| 82550 | 2,629 | 2,363 | $14K | |
| C1729 | Catheter, drainage | 2,003 | 1,842 | $14K |
| 87101 | 1,705 | 1,672 | $14K | |
| 90710 | 1,464 | 1,438 | $14K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 4,668 | 4,421 | $13K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 2,702 | 2,488 | $13K |
| 84156 | 4,724 | 4,321 | $12K | |
| 82657 | 797 | 386 | $12K | |
| 80299 | 586 | 527 | $12K | |
| 85730 | 4,319 | 3,915 | $12K | |
| 86308 | 1,856 | 1,796 | $12K | |
| 97033 | 418 | 152 | $12K | |
| 85014 | 7,766 | 5,543 | $12K | |
| 82565 | 3,776 | 3,538 | $12K | |
| 90661 | 1,435 | 1,430 | $12K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 67 | 63 | $11K |
| 84145 | 1,014 | 905 | $11K | |
| 95715 | 16 | 13 | $11K | |
| 83605 | 1,261 | 1,183 | $11K | |
| 86160 | 1,420 | 1,325 | $11K | |
| 90716 | 1,382 | 1,333 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 92 | 90 | $11K |
| 95708 | 15 | 15 | $11K | |
| 97113 | 199 | 82 | $11K | |
| 90707 | 1,357 | 1,309 | $11K | |
| 77080 | 83 | 77 | $11K | |
| 92652 | 76 | 63 | $10K | |
| 83615 | 4,904 | 4,049 | $10K | |
| 84295 | 2,740 | 2,498 | $10K | |
| 90620 | 937 | 919 | $10K | |
| 12002 | 37 | 37 | $10K | |
| 90380 | 53 | 36 | $10K | |
| 97750 | 234 | 214 | $10K | |
| 96139 | 87 | 40 | $9K | |
| 90480 | 237 | 234 | $9K | |
| J0290 | Injection, ampicillin sodium, 500 mg | 1,339 | 910 | $8K |
| 71250 | 26 | 26 | $8K | |
| 84132 | 3,868 | 2,933 | $8K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 65 | 29 | $8K |
| 84450 | 3,019 | 2,822 | $8K | |
| 72110 | 97 | 91 | $8K | |
| 84550 | 5,296 | 4,411 | $8K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,514 | 1,824 | $8K |
| 51701 | 1,235 | 1,162 | $8K | |
| 86480 | 739 | 718 | $8K | |
| 84460 | 3,133 | 2,922 | $8K | |
| 87075 | 314 | 295 | $7K | |
| 90734 | 714 | 695 | $7K | |
| 73120 | 126 | 107 | $7K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,376 | 1,726 | $7K |
| 76800 | 42 | 37 | $7K | |
| 92607 | 27 | 25 | $7K | |
| 84484 | 488 | 454 | $7K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,747 | 1,422 | $7K |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 445 | 402 | $7K |
| 77076 | 109 | 101 | $7K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 784 | 714 | $6K |
| 86430 | 1,409 | 1,352 | $6K | |
| 99205 | Prolong outpt/office vis | 46 | 39 | $6K |
| 16020 | 27 | 25 | $6K | |
| 88302 | 991 | 929 | $6K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 1,021 | 942 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | 350 | 139 | $6K |
| 89051 | 1,438 | 1,145 | $6K | |
| 64642 | 56 | 50 | $6K | |
| 36416 | 4,613 | 3,397 | $5K | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 1,030 | 854 | $5K |
| 97166 | 41 | 40 | $5K | |
| 96132 | 60 | 47 | $5K | |
| 93975 | 12 | 12 | $5K | |
| 82465 | 2,560 | 2,044 | $5K | |
| 74270 | 25 | 25 | $5K | |
| 82272 | 1,329 | 1,252 | $5K | |
| 24640 | 12 | 12 | $5K | |
| 87807 | 456 | 439 | $5K | |
| 83993 | 538 | 523 | $5K | |
| 86008 | 464 | 439 | $5K | |
| 17250 | 12 | 12 | $4K | |
| 90672 | 328 | 328 | $4K | |
| J9370 | Vincristine sulfate, 1 mg | 893 | 606 | $4K |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 461 | 425 | $4K |
| 86665 | 371 | 355 | $4K | |
| 87102 | 315 | 297 | $4K | |
| 92585 | 27 | 26 | $4K | |
| J2182 | Injection, mepolizumab, 1 mg | 26 | 24 | $4K |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | 446 | 321 | $4K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 669 | 601 | $4K |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | 130 | 125 | $3K |
| 29130 | 58 | 54 | $3K | |
| 12051 | 13 | 12 | $3K | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 213 | 116 | $3K |
| 86663 | 341 | 329 | $3K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 418 | 382 | $3K |
| 96137 | 43 | 37 | $3K | |
| L3260 | Surgical boot/shoe, each | 166 | 155 | $3K |
| 0071A | 61 | 61 | $3K | |
| 91322 | 98 | 97 | $3K | |
| 74022 | 40 | 40 | $3K | |
| 84480 | 450 | 416 | $3K | |
| 86039 | 505 | 483 | $2K | |
| 29540 | 13 | 13 | $2K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 104 | 12 | $2K |
| 94726 | 25 | 24 | $2K | |
| 0072A | 53 | 53 | $2K | |
| 94729 | 41 | 37 | $2K | |
| 74183 | 14 | 12 | $2K | |
| 31720 | 26 | 25 | $2K | |
| 0002A | 59 | 59 | $2K | |
| 96131 | 44 | 39 | $2K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 45 | 37 | $2K |
| 86664 | 361 | 349 | $2K | |
| 93971 | 14 | 12 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 265 | 235 | $2K |
| 90474 | 3,617 | 3,362 | $2K | |
| 83970 | 532 | 452 | $2K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 109 | 54 | $2K |
| 94761 | 1,581 | 1,436 | $2K | |
| 0001A | 60 | 59 | $2K | |
| 82270 | 488 | 446 | $2K | |
| 85245 | 169 | 161 | $2K | |
| 85384 | 464 | 400 | $2K | |
| 96411 | 15 | 12 | $2K | |
| 87529 | 105 | 94 | $2K | |
| 88342 | 154 | 142 | $2K | |
| 96381 | 199 | 157 | $2K | |
| J7510 | Prednisolone oral, per 5 mg | 816 | 676 | $2K |
| J7999 | Compounded drug, not otherwise classified | 509 | 487 | $1K |
| 87081 | 352 | 327 | $1K | |
| 96138 | 47 | 40 | $1K | |
| 80164 | 131 | 118 | $1K | |
| J7699 | Noc drugs, inhalation solution administered through dme | 511 | 426 | $1K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 441 | 290 | $1K |
| A4565 | Slings | 196 | 186 | $1K |
| 83986 | 450 | 389 | $1K | |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | 55 | 54 | $1K |
| 85246 | 201 | 191 | $1K | |
| J3489 | Injection, zoledronic acid, 1 mg | 13 | 12 | $1K |
| 85240 | 98 | 91 | $992.82 | |
| 94760 | 1,470 | 1,334 | $956.09 | |
| 91321 | 110 | 110 | $923.63 | |
| 84478 | 302 | 263 | $891.21 | |
| 64448 | 18 | 14 | $829.95 | |
| 85379 | 57 | 55 | $745.21 | |
| 88313 | 48 | 44 | $717.84 | |
| 80349 | 106 | 103 | $714.87 | |
| 82010 | 103 | 92 | $710.58 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 189 | 162 | $697.08 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 321 | 238 | $686.05 |
| 90381 | 82 | 78 | $628.02 | |
| 93296 | 19 | 15 | $561.46 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 50 | 43 | $523.03 |
| 0124A | 17 | 14 | $518.59 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 76 | 54 | $507.83 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 252 | 205 | $487.92 |
| 82533 | 26 | 25 | $475.71 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 63 | 51 | $469.01 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 162 | 158 | $460.03 |
| 87252 | 13 | 12 | $440.11 | |
| 85055 | 75 | 43 | $429.99 | |
| 80069 | 78 | 68 | $420.76 | |
| 90473 | 178 | 178 | $415.35 | |
| 87496 | 14 | 13 | $398.06 | |
| 82310 | 579 | 194 | $381.48 | |
| 86769 | 64 | 38 | $349.76 | |
| 84157 | 360 | 304 | $339.34 | |
| 83718 | 27 | 27 | $329.68 | |
| 90732 | 13 | 12 | $324.30 | |
| 82040 | 69 | 69 | $323.48 | |
| 84703 | 37 | 36 | $321.83 | |
| S0080 | Injection, pentamidine isethionate, 300 mg | 12 | 12 | $317.04 |
| J2060 | Injection, lorazepam, 2 mg | 56 | 52 | $306.20 |
| 82670 | 174 | 163 | $299.65 | |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 150 | 71 | $280.23 |
| 82945 | 256 | 218 | $275.46 | |
| 87220 | 74 | 72 | $246.69 | |
| 82607 | 58 | 56 | $222.54 | |
| 84520 | 245 | 147 | $222.10 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 75 | 61 | $217.31 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 28 | 25 | $198.46 |
| 85670 | 21 | 12 | $194.04 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 17 | 14 | $173.75 |
| 99199 | Unlisted special service, procedure or report | 22 | 22 | $169.40 |
| 86803 | 199 | 198 | $161.98 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 33 | 26 | $152.12 |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 14 | 12 | $149.88 |
| 86706 | 224 | 218 | $146.66 | |
| 86880 | 41 | 39 | $146.15 | |
| 87118 | 14 | 14 | $143.15 | |
| 90785 | 14 | 14 | $140.92 | |
| 29505 | 13 | 12 | $136.22 | |
| 87206 | 14 | 14 | $131.90 | |
| 83002 | 352 | 336 | $130.13 | |
| 82438 | 13 | 13 | $118.82 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 16 | 12 | $115.68 |
| 89055 | 31 | 27 | $109.97 | |
| 83519 | 240 | 231 | $107.41 | |
| 84134 | 12 | 12 | $99.09 | |
| 82340 | 39 | 37 | $98.12 | |
| 86225 | 104 | 100 | $73.70 | |
| 82140 | 15 | 14 | $73.58 | |
| 85651 | 15 | 14 | $71.52 | |
| 84402 | 217 | 209 | $71.33 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 13 | 12 | $54.01 |
| 87184 | 16 | 15 | $46.13 | |
| 87340 | 292 | 280 | $40.65 | |
| 87147 | 14 | 13 | $34.24 | |
| 82435 | 69 | 59 | $32.88 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 92 | 80 | $29.37 |
| 86255 | 24 | 24 | $28.00 | |
| 87497 | 14 | 13 | $24.01 | |
| 82610 | 145 | 130 | $8.31 | |
| J9250 | Methotrexate sodium, 5 mg | 14 | 13 | $6.66 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 402 | 362 | $5.45 |
| A4606 | Oxygen probe for use with oximeter device, replacement | 617 | 551 | $5.33 |
| 91312 | 17 | 14 | $5.09 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 28 | 14 | $2.46 |
| A4550 | Surgical trays | 40 | 37 | $0.00 |
| G9920 | Screening performed and negative | 3,719 | 3,673 | $0.00 |
| 82627 | 26 | 26 | $0.00 | |
| 84030 | 49 | 44 | $0.00 | |
| 86235 | 14 | 14 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 436 | 389 | $0.00 |
| A4218 | Sterile saline or water, metered dose dispenser, 10 ml | 18 | 17 | $0.00 |
| 96136 | 14 | 13 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 118 | 117 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 40 | 37 | $0.00 |
| 87799 | 39 | 36 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 809 | 798 | $0.00 |
| 90685 | 29 | 24 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 518 | 508 | $0.00 |
| 86352 | 41 | 41 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 364 | 359 | $0.00 |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 473 | 443 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2,866 | 2,551 | $0.00 |
| 83498 | 13 | 13 | $0.00 |